Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - ondansetron hydrochloride dihydrate, quantity: 10 mg (equivalent: ondansetron, qty 8 mg) - injection, solution - excipient ingredients: citric acid monohydrate; sodium citrate dihydrate; sodium chloride; water for injections - ondansetron injection is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ondansetron injection is also indicated for the prevention and treatment of post-operative nausea and vomiting.

New Zealand - English - Medsafe (Medicines Safety Authority)

rex medical ltd - ondansetron hydrochloride dihydrate 2.5 mg/ml equivalent to ondansetron 2 mg - solution for injection - 2 mg/ml - active: ondansetron hydrochloride dihydrate 2.5 mg/ml equivalent to ondansetron 2 mg excipient: citric acid sodium chloride sodium citrate dihydrate water for injection - onrex injection is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - ondansetron hydrochloride dihydrate 2.5 mg/ml equivalent to ondansetron 2 mg/ml - solution for injection - 2 mg/ml - active: ondansetron hydrochloride dihydrate 2.5 mg/ml equivalent to ondansetron 2 mg/ml excipient: citric acid monohydrate sodium chloride sodium citrate dihydrate water for injection

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 5 mg (equivalent: ondansetron, qty 4 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; pregelatinised maize starch; sodium starch glycollate; colloidal anhydrous silica; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 400 - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Canada - English - Health Canada

sandoz canada incorporated - ondansetron (ondansetron hydrochloride dihydrate) - solution - 2mg - ondansetron (ondansetron hydrochloride dihydrate) 2mg - 5-ht3 receptor antagonists

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 5 mg (equivalent: ondansetron, qty 4 mg) - tablet, film coated - excipient ingredients: pregelatinised maize starch; microcrystalline cellulose; sodium starch glycollate; lactose monohydrate; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 400 - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 5 mg (equivalent: ondansetron, qty 4 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; pregelatinised maize starch; sodium starch glycollate; colloidal anhydrous silica; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 400 - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 4.98 mg (equivalent: ondansetron, qty 4 mg) - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium chloride; citric acid monohydrate; water for injections - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. prevention and treatment of post-operative nausea and vomiting.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - ondansetron hydrochloride dihydrate 2.49 mg/ml equivalent to ondansetron 2 mg/ml - solution for injection - 4 mg/2ml - active: ondansetron hydrochloride dihydrate 2.49 mg/ml equivalent to ondansetron 2 mg/ml excipient: citric acid nitrogen sodium chloride sodium citrate water for injection - ondansetron is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy (in adults, adolescents and children) and radiotherapy (in adults). ondansetron (injection) is also indicated for the prevention and treatment of post-operative nausea and vomiting in adults, adolescents and children.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - ondansetron hydrochloride dihydrate 2.49 mg/ml equivalent to ondansetron 2 mg/ml - solution for injection - 8 mg/4ml - active: ondansetron hydrochloride dihydrate 2.49 mg/ml equivalent to ondansetron 2 mg/ml excipient: citric acid nitrogen sodium chloride sodium citrate water for injection - ondansetron is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy (in adults, adolescents and children) and radiotherapy (in adults). ondansetron (injection) is also indicated for the prevention and treatment of post-operative nausea and vomiting in adults, adolescents and children.